207 related articles for article (PubMed ID: 19480935)
21. High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9.
von Bergh AR; van Drunen E; van Wering ER; van Zutven LJ; Hainmann I; Lönnerholm G; Meijerink JP; Pieters R; Beverloo HB
Genes Chromosomes Cancer; 2006 Aug; 45(8):731-9. PubMed ID: 16646086
[TBL] [Abstract][Full Text] [Related]
22. Insertion of the 5' part of BCR within the ABL gene at 9q34 in a Philadelphia-negative chronic myeloid leukemia.
Vieira L; Alves AC; Marques B; Reis I; Jorge G; Ambrósio AP; de Sousa AB; Boavida MG
Cancer Genet Cytogenet; 1999 Oct; 114(1):17-21. PubMed ID: 10526530
[TBL] [Abstract][Full Text] [Related]
23. Molecular cytogenetic findings in a four-way t(1;12;5;12)(p36;p13;q33;q24) underlying the ETV6-PDGFRB fusion gene in chronic myelomonocytic leukemia.
Crescenzi B; La Starza R; Nozzoli C; Ciolli S; Matteucci C; Romoli S; Rigacci L; Gorello P; Bosi A; Martelli MF; Marynen P; Mecucci C
Cancer Genet Cytogenet; 2007 Jul; 176(1):67-71. PubMed ID: 17574967
[TBL] [Abstract][Full Text] [Related]
24. A Philadelphia-negative chronic myeloid leukemia with a BCR/ABL fusion gene on chromosome 9.
Reddy KS; Grove B
Cancer Genet Cytogenet; 1998 Nov; 107(1):48-50. PubMed ID: 9809034
[TBL] [Abstract][Full Text] [Related]
25. Cytogenetic, fluorescence in situ hybridization, and molecular characterization of chronic myeloid leukemia in chronic phase with four BCR/ABL1 fusion signals: a case report.
Vargas MT; Portero MA; Rodríguez A; Reyes J; Fernández-Novoa C
Cancer Genet Cytogenet; 2009 Nov; 195(1):71-4. PubMed ID: 19837272
[TBL] [Abstract][Full Text] [Related]
26. Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib.
Schafhausen P; Dierlamm J; Bokemeyer C; Bruemmendorf TH; Bacher U; Zander AR; Schnittger S; Hochhaus A
Cancer Genet Cytogenet; 2009 Feb; 189(1):63-7. PubMed ID: 19167615
[No Abstract] [Full Text] [Related]
27. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P
Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300
[TBL] [Abstract][Full Text] [Related]
28. Presence of t(1;14)(p13;p11.2) in Philadelphia chromosome-negative cells in a patient with chronic myeloid leukemia.
Medeiros BC; Markovic V; Kamel-Reid S; Lipton JH
Cancer Genet Cytogenet; 2007 Feb; 173(1):83-4. PubMed ID: 17284377
[No Abstract] [Full Text] [Related]
29. Chronic myelocytic leukemia with eosinophilia, t(9;12)(q34;p13), and ETV6-ABL gene rearrangement: case report and review of the literature.
Keung YK; Beaty M; Steward W; Jackle B; Pettnati M
Cancer Genet Cytogenet; 2002 Oct; 138(2):139-42. PubMed ID: 12505259
[TBL] [Abstract][Full Text] [Related]
30. Molecular cytogenetic characterization of rearrangements involving 12p in leukemia.
Vieira L; Marques B; Cavaleiro C; Ambrósio AP; Jorge M; Neto A; Costa JM; Júnior EC; Boavida MG
Cancer Genet Cytogenet; 2005 Mar; 157(2):134-9. PubMed ID: 15721634
[TBL] [Abstract][Full Text] [Related]
31. A constitutively active SPTBN1-FLT3 fusion in atypical chronic myeloid leukemia is sensitive to tyrosine kinase inhibitors and immunotherapy.
Grand FH; Iqbal S; Zhang L; Russell NH; Chase A; Cross NC
Exp Hematol; 2007 Nov; 35(11):1723-7. PubMed ID: 17764812
[TBL] [Abstract][Full Text] [Related]
32. A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma.
Makretsov N; He M; Hayes M; Chia S; Horsman DE; Sorensen PH; Huntsman DG
Genes Chromosomes Cancer; 2004 Jun; 40(2):152-7. PubMed ID: 15101049
[TBL] [Abstract][Full Text] [Related]
33. Next-generation sequencing and molecular cytogenetic characterization of ETV6-LYN fusion due to chromosomes 1, 8 and 12 rearrangement in acute myeloid leukemia.
Ma ESK; Wan TSK; Au CH; Ho DN; Ma SY; Ng MHL; Chan TL
Cancer Genet; 2017 Dec; 218-219():15-19. PubMed ID: 29153093
[TBL] [Abstract][Full Text] [Related]
34. Translocation (9;12)(q34.1;p13.?3) Resulted in ETV6-ABL1 Fusion in a Patient with Philadelphia Chromosome-Negative Chronic Myelogenous Leukemia.
Mori N; Ohwashi-Miyazaki M; Okada M; Yoshinaga K; Shiseki M; Tanaka J
Acta Haematol; 2016; 136(4):240-243. PubMed ID: 27710957
[No Abstract] [Full Text] [Related]
35. ETV6-NCOA2: a novel fusion gene in acute leukemia associated with coexpression of T-lymphoid and myeloid markers and frequent NOTCH1 mutations.
Strehl S; Nebral K; König M; Harbott J; Strobl H; Ratei R; Struski S; Bielorai B; Lessard M; Zimmermann M; Haas OA; Izraeli S
Clin Cancer Res; 2008 Feb; 14(4):977-83. PubMed ID: 18281529
[TBL] [Abstract][Full Text] [Related]
36. Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia.
Foroni L; Gerrard G; Nna E; Khorashad JS; Stevens D; Swale B; Milojkovic D; Reid A; Goldman J; Marin D
Am J Hematol; 2009 Aug; 84(8):517-22. PubMed ID: 19544476
[TBL] [Abstract][Full Text] [Related]
37. [Chronic myeloid leukemia without Philadelphia chromosome (Ph-negative CML)].
Haus O
Acta Haematol Pol; 1993; 24(3):221-5. PubMed ID: 8249537
[TBL] [Abstract][Full Text] [Related]
38. Characterization of leukemias with ETV6-ABL1 fusion.
Zaliova M; Moorman AV; Cazzaniga G; Stanulla M; Harvey RC; Roberts KG; Heatley SL; Loh ML; Konopleva M; Chen IM; Zimmermannova O; Schwab C; Smith O; Mozziconacci MJ; Chabannon C; Kim M; Frederik Falkenburg JH; Norton A; Marshall K; Haas OA; Starkova J; Stuchly J; Hunger SP; White D; Mullighan CG; Willman CL; Stary J; Trka J; Zuna J
Haematologica; 2016 Sep; 101(9):1082-93. PubMed ID: 27229714
[TBL] [Abstract][Full Text] [Related]
39. The Tel-Abl (ETV6-Abl) tyrosine kinase, product of complex (9;12) translocations in human leukemia, induces distinct myeloproliferative disease in mice.
Million RP; Aster J; Gilliland DG; Van Etten RA
Blood; 2002 Jun; 99(12):4568-77. PubMed ID: 12036890
[TBL] [Abstract][Full Text] [Related]
40. Extramedullary T-lymphoid blast crisis of an ETV6/ABL1-positive myeloproliferative neoplasm with t(9;12)(q34;p13) and t(7;14)(p13;q11.2).
Yamamoto K; Yakushijin K; Nakamachi Y; Miyata Y; Sanada Y; Tanaka Y; Okamura A; Kawano S; Hayashi Y; Matsuoka H; Minami H
Ann Hematol; 2014 Aug; 93(8):1435-8. PubMed ID: 24318592
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
